Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

654 ARTÍCULOS , VIENDO DEL 271 AL 285

Metoclopramide induced acute dystonic reaction: A case report

Sheikh Hassan M, Ahmed Nor M.

Ann Med Surg (Lond). 2022 Jan 11;74:103248. doi: 10.1016/j.amsu.2022.103248. eCollection 2022 Feb.

Effects of rasagiline on Parkinson's Disease Questionnaire (PDQ-39) emotional well-being domain in patients with Parkinson's disease: A post-hoc analysis of clinical trials in Japan

Hattori N, Takeda A, Hanya Y, Kitagawa T, Arai M, Furusawa Y, Mochizuki H, Nagai M, Takahashi R.

PLoS One. 2022 Jan 25;17(1):e0262796. doi: 10.1371/journal.pone.0262796. eCollection 2022.

Criteria for identification of advanced Parkinson's disease: the results of the Italian subgroup of OBSERVE-PD observational study

Stefani A, Tessitore A, Tambasco N, Cossu G, Ceravolo MG, Defazio G, Morgante F, Ramat S, Melzi G, Gualberti G, Merolla R, Onuk K, Lopiano L.

BMC Neurol. 2022 Jan 28;22(1):41. doi: 10.1186/s12883-022-02554-z.

Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy

Korb M, Peck A, Alfano LN, Berger KI, James MK, Ghoshal N, Healzer E, Henchcliffe C, Khan S, Mammen PPA, Patel S, Pfeffer G, Ralston SH, Roy B, Seeley WW, Swenson A, Mozaffar T, Weihl C, Kimonis V; VCP Standards of Care Working Group.

Orphanet J Rare Dis. 2022 Jan 29;17(1):23. doi: 10.1186/s13023-022-02172-5.

Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research

Valdovinos BY, Modica JS, Schneider RB.

Curr Neurol Neurosci Rep. 2022 Feb;22(2):113-122. doi: 10.1007/s11910-022-01178-7. Epub 2022 Feb 2.

Effects of Endurance Training on Motor Signs of Parkinson's Disease: A Systematic Review and Meta-Analysis

de Almeida FO, Santana V, Corcos DM, Ugrinowitsch C, Silva-Batista C.

Sports Med. 2022 Aug;52(8):1789-1815. doi: 10.1007/s40279-022-01650-x. Epub 2022 Feb 3.

Neuropsychiatric Treatments for Parkinson's Disease: Nonpharmacological Approaches

Mathur N, Bhatt H, Lidstone SC.

Semin Neurol. 2022 Apr;42(2):158-167. doi: 10.1055/s-0041-1742266. Epub 2022 Feb 3.

Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches

Huang Y, Wei J, Cooper A, Morris MJ.

Genes Dis. 2022 Feb 5;10(3):786-798. doi: 10.1016/j.gendis.2021.12.015. eCollection 2023 May.

Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers

Barba L, Paolini Paoletti F, Bellomo G, Gaetani L, Halbgebauer S, Oeckl P, Otto M, Parnetti L.

Mov Disord. 2022 Apr;37(4):669-683. doi: 10.1002/mds.28941. Epub 2022 Feb 5.

Tremor as a symptom of degenerative cervical myelopathy: a systematic review

El Khoury M, Mowforth OD, El Khoury A, Partha-Sarathi C, Hirayama Y, Davies BM, Kotter MR.

Br J Neurosurg. 2022 Jun;36(3):340-345. doi: 10.1080/02688697.2022.2033701. Epub 2022 Feb 8.

Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia

Scarduzio M, Hess EJ, Standaert DG, Eskow Jaunarajs KL.

Neurobiol Dis. 2022 May;166:105650. doi: 10.1016/j.nbd.2022.105650. Epub 2022 Feb 6.

Finely-tuned gamma oscillations: Spectral characteristics and links to dyskinesia

Wiest C, Torrecillos F, Tinkhauser G, Pogosyan A, Morgante F, Pereira EA, Tan H.

Exp Neurol. 2022 May;351:113999. doi: 10.1016/j.expneurol.2022.113999. Epub 2022 Feb 7.

Sudden unexpected death in Parkinson's disease: Insights from clinical practice

Scorza FA, Guimarães-Marques M, Nejm M, de Almeida ACG, Scorza CA, Fiorini AC, Finsterer J.

Clinics (Sao Paulo). 2022 Feb 10;77:100001. doi: 10.1016/j.clinsp.2021.100001. eCollection 2022.

Lateralized Subthalamic Stimulation for Axial Dysfunction in Parkinson's Disease: A Randomized Trial

Lizárraga KJ, Gnanamanogaran B, Al-Ozzi TM, Cohn M, Tomlinson G, Boutet A, Elias GJB, Germann J, Soh D, Kalia SK, Hodaie M, Munhoz RP, Marras C, Hutchison WD, Lozano AM, Lang AE, Fasano A.

Mov Disord. 2022 May;37(5):1079-1087. doi: 10.1002/mds.28953. Epub 2022 Feb 13.

Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders

Toledo ARL, Monroy GR, Salazar FE, Lee JY, Jain S, Yadav H, Borlongan CV.

Int J Mol Sci. 2022 Jan 21;23(3):1184. doi: 10.3390/ijms23031184.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias